BEGIN:VCALENDAR
PRODID:NingEventWidget-v1
VERSION:2.0
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:2140535:Event:63605
DTSTAMP:20260520T161907Z
SUMMARY:U.S Veterinary Biological Development and Registration
DESCRIPTION:Overview: The Development of veterinary biologics, involve
 s a complex series of clinical studies and analytical programs to assu
 re the quality and effectiveness of these products. Biologicals are co
 mmonly vaccines and include conventional viral based products, bacteri
 ns, toxins, rDNA products and antibody products. The basic developmen
 t programs for theses vaccines are similar, but differences will be hi
 ghlighted. It should be recognized that unlike human vaccines the Cent
 er for Veterinary Biologics registers hundreds of types of vaccines, b
 ut all are developed and registered using the Master Seed concept to a
 ssure vaccines made years from now, and those developed years ago are 
 made according to the same standards and the consumers can expect the 
 same quality. Why should you Attend:Veterinary Biologicals - largely 
 vaccines but also antibody products and certain test kits are commonly
  used in both our Companion Animals (cats, dogs, horses) and Livestock
  (cattle, swine, poultry and fish) to prevent and occasionally treat d
 isease. Some of the diseases prevented by these products are for zoono
 tic diseases such as Rabies and Leptospirosis which can have serious i
 f not fatal outcomes in humans. Areas Covered in the Session:\nOver o
 f the regulatory framework for veterinary biological and how if differ
 s from pharmaceutical products, and the United State Departments of Ag
 ricultures Center for Veterinary Biologics\nMaster Seed concept\nClini
 cal program for Efficacy\nClinical program for Safety\nAnalytical/manu
 facturing requirements\nLabeling\nImport and export considerations\nQ&
 A\n\nWho Will Benefit:\n\nResearchers\nVeterinarians\nStart up venture
 s including vaccine companies\nStudents considering careers in veterin
 ary Biologicals\nLivestock producers\n\n\n\n\nHans Draayer has over 3
 0 years of experience in the biological industry working for major cor
 porations including Pfizer, SmithKline Beecham and Beecham Laboratorie
 s. During this time he has held various senior Regulatory and R&D mana
 gement roles and has developed and licensed vaccines for all major spe
 cies with the USDA Center for Veterinary Biologics. \n\nQuick Contact
 :\nGlobalCompliancePanel USA Phone:800-447-9407webinars@globalcomplian
 cepanel.comhttp://www.globalcompliancepanel.comEvent Link -http://bit.
 ly/1ahG9Vd\n\n\n\n\n\nFor more information visit https://medtechiq.nin
 g.com/events/u-s-veterinary-biological-development-and-registration
DTSTART;TZID=America/New_York:20140328T100000
DTEND;TZID=America/New_York:20140328T110000
CATEGORIES:webinar, pharma, medical, clinical, health
LOCATION:Online Event
WEBSITE:http://bit.ly/1ahG9Vd
URL:http://bit.ly/1ahG9Vd
CONTACT:8004479407
ORGANIZER:GlobalCompliancePanel
ATTACH;FMTTYPE="image/jpeg":http://storage.ning.com/topology/rest/1.0/
 file/get/2562011838?profile=original
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE;CN="John Rob
 inson":https://medtechiq.ning.com/profile/JohnRobinson
END:VEVENT
END:VCALENDAR